Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Docetaxel|DRUG: Capecitabine
Sponsor: M.D. Anderson Cancer Center
Collaborators: Roche Pharma AG